Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Call9 was a healthcare technology company that specialized in providing emergency medical services to residents of skilled nursing facilities through a hybrid telemedicine model. Founded in 2015 by Dr. Timothy Peck, the company placed emergency-trained first responders on-site 24/7 to facilitate immediate video consultations with remote emergency physicians. This "high-tech, high-touch" approach was designed to bypass the traditional 911 system, significantly reducing unnecessary hospital transfers and associated costs. At its peak, Call9 managed thousands of patients daily and partnered with major insurers like Anthem and Aetna. However, the company ceased operations in 2019 following financial difficulties and shifts in the regulatory landscape for telehealth reimbursement.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Call9.